Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)
Go back to Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 56.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.78 | 52 Week High | $19.98 | |||
| Open | $56.78 | 52 Week Low | $10.52 | |||
| Day High | $56.78 | P/E | N/A | |||
| Day Low | $56.78 | EPS | $-1.45 | |||
| Volume | 222 | |||||
